Last updated: 2026-09-09 11:52:00. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.
Cumberland Pharmaceuticals Inc. (CPIX) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $6.75, with a market capitalization of $101.74M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $1.85 to $9.28. This page covers its latest market performance, valuation, price trends and company information.
$101.74M | |
$6.71 | |
$17.75 | |
$1.04 | |
$6.62 | |
71.00 | |
91.69K | |
-- | |
$9.28 | |
$1.85 | |
-- | |
-- |
Cumberland Pharmaceuticals Inc. (CPIX) is trading at $6.75 in pre-market trading as of 2026-09-09 11:32:00, up 1.96% ($0.13) from the previous close of $6.62
Pre-market trading shows how investors are pricing CPIX before the regular session opens. The current pre-market price is above the previous close, indicating positive early trading sentiment.
Over the past seven days, Cumberland Pharmaceuticals Inc. (CPIX) moved from $8.46 to $6.75, representing a decline of 20.21% ($1.71).
The stock traded between $6.28 and $9.16 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 61.86 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 65.9%
CPIX is currently trading at $6.75, placing it 65.9% of the way from its 52-week low of $1.85 to its 52-week high of $9.28. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment, which is specialty pharmaceutical products. The company's target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The firm promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. Its brands include Acetadote, Caldolor, Kristalose, Sancuso, Vaprisol, and Vibativ. Geographically, the company generates revenue from China, South Korea, Russia, Mexico, Australia, and Saudi Arabia.
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 93 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Cumberland Pharmaceuticals Inc. (CPIX) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.